Literature DB >> 30357607

Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis.

Yi Shen1, Jie Zhou1, Sheng Zhang1, Xu-Lin Wang1, Yu-Long Jia1, Shu He1, Yuan-Yuan Wang1, Wen-Chao Li1, Jian-Guo Shao2, Xun Zhuang1, Yuan-Lin Liu3, Gang Qin4.   

Abstract

BACKGROUND AND
OBJECTIVE: Although many meta-analyses have evaluated the pharmacotherapy of intrahepatic cholestasis of pregnancy (ICP) and recommended ursodeoxycholic acid (UDCA) as an effective treatment, the defect of the pair-wise analyses and the mixture of the control group made the outcome uncertain and unclear. We aimed to employ Bayesian network meta-analysis (NMA) to compare the maternal and fetal outcomes after UDCA, S-adenosylmethionine (SAMe) mono-therapy or the combination treatment of these two drugs for ICP patients.
METHODS: Multiple electronic database searches were conducted for articles published up to 1 September 2018. The relevant information was extracted from the published reports with a predefined data extraction sheet, and the risk of bias was assessed with the Cochrane risk-of-bias tool. Poisson Bayesian network meta-analysis was employed to identify the synthesized evidence from the relevant trials, with reporting hazard risks (HRs) and 95% credible intervals (CrIs).
RESULTS: The pooled outcomes of the 13 randomized controlled trials (RCTs) with 625 participants indicated that none of the three regimens can significantly improve maternal and fetal outcomes.
CONCLUSION: This NMA of the RCTs clarified that the current intervention has no favorable effect on pruritus and other symptoms in ICP patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30357607     DOI: 10.1007/s40261-018-0717-2

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  61 in total

Review 1.  Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management.

Authors:  F Lammert; H U Marschall; A Glantz; S Matern
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

2.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.

Authors:  Fujian Song; Douglas G Altman; Anne-Marie Glenny; Jonathan J Deeks
Journal:  BMJ       Date:  2003-03-01

3.  How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.

Authors:  Paul C Lambert; Alex J Sutton; Paul R Burton; Keith R Abrams; David R Jones
Journal:  Stat Med       Date:  2005-08-15       Impact factor: 2.373

Review 4.  [Cholestasis of pregnancy].

Authors:  Sara Lorente; Miguel A Montoro
Journal:  Gastroenterol Hepatol       Date:  2007-11       Impact factor: 2.102

Review 5.  Use of indirect and mixed treatment comparisons for technology assessment.

Authors:  Alex Sutton; A E Ades; Nicola Cooper; Keith Abrams
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy.

Authors:  Yuling Liu; Fuyuan Qiao; Haiyi Liu; Dayan Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

7.  Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.

Authors:  Tomás Binder; Peter Salaj; Tomás Zima; Libor Vítek
Journal:  J Perinat Med       Date:  2006       Impact factor: 1.901

8.  Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Frank Lammert; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

9.  A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.

Authors:  Nadia Roncaglia; Anna Locatelli; Alessandra Arreghini; Francesca Assi; Irene Cameroni; John C Pezzullo; Alessandro Ghidini
Journal:  BJOG       Date:  2004-01       Impact factor: 6.531

10.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  2 in total

1.  Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.

Authors:  Caroline Ovadia; Jenna Sajous; Paul T Seed; Kajol Patel; Nicholas J Williamson; George Attilakos; Francesco Azzaroli; Yannick Bacq; Linoy Batsry; Kelsey Broom; Romana Brun-Furrer; Laura Bull; Jenny Chambers; Yue Cui; Min Ding; Peter H Dixon; Maria C Estiú; Fergus W Gardiner; Victoria Geenes; Monika Grymowicz; Berrin Günaydin; William M Hague; Christian Haslinger; Yayi Hu; Ugo Indraccolo; Alexander Juusela; Stefan C Kane; Ayse Kebapcilar; Levent Kebapcilar; Katherine Kohari; Jūratė Kondrackienė; Maria P H Koster; Richard H Lee; Xiaohua Liu; Anna Locatelli; Rocio I R Macias; Riza Madazli; Agata Majewska; Kasia Maksym; Jessica A Marathe; Adam Morton; Martijn A Oudijk; Deniz Öztekin; Michael J Peek; Andrew H Shennan; Rachel M Tribe; Valeria Tripodi; Naciye Türk Özterlemez; Tharni Vasavan; L F Audris Wong; Yoav Yinon; Qianwen Zhang; Keren Zloto; Hanns-Ulrich Marschall; Jim Thornton; Lucy C Chappell; Catherine Williamson
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-04-27

2.  The impact of assisted reproductive technology in twin pregnancies complicated by intrahepatic cholestasis: a five-year retrospective study.

Authors:  Yunhui Gong; Xinghui Liu; Qianwen Zhang; Yu Xu
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-31       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.